Pembrolizumab or Placebo Plus Adjuvant Chemotherapy with or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors.Brian M. Slomovitz,David Cibula,Weiguo Lv,Firat Ortac,Sakari Hietanen,Floor Backes,Akira Kikuchi,Domenica Lorusso,Anna Danska-Bidzinska,Vanessa Samouelian,Maria-Pilar Barretina-Ginesta,Christof Vulsteke,Chyong-Huey Lai,Bhavana Pothuri,Yu Zhang, Manuel Magallanes-Maciel,Amnon Amit,Valentina Guarneri,Flora Zagouri,Maria Bell, Julia Welz,Gemma Eminowicz,Martin Hruda,Lyndsay J. Willmott, Jasmine Lichfield,Wei Wang,Robert Orlowski,Gursel Aktan,Laurence Gladieff,Toon Van GorpJOURNAL OF CLINICAL ONCOLOGY(2025)引用 0|浏览1AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要